Loading...
Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
Pancreatic cancer is one of the leading causes of cancer death worldwide. Adjuvant chemotherapy has been developed based on the experiences made with palliative chemotherapy, and advocated to improve long-term survival of patients with this disease. However, the optimal chemotherapeutic regimen rema...
Na minha lista:
| Udgivet i: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589737/ https://ncbi.nlm.nih.gov/pubmed/31249443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i23.2839 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|